Ruconest provides clinically meaningful relief of symptons in phase II study Oct. 2, 2017 No Comments
Topline results reported from Japanese phase II study of vadadustat in NDD-CKD Sep. 27, 2017 No Comments
Catalyst Biosciences' CB-2679d awarded FDA orphan drug status for hemophilia B Sep. 27, 2017 No Comments
RSS